September, 2019

article thumbnail

What Are The Reasons Of Popularization And Future Aspects Of Pharma Franchise Business?

Fossil Remedies

POPULARIZATION AND FUTURE ASPECTS OF PHARMA FRANCHISE BUSINESS. Are you planning to launch a pharma franchise business? If yes, then it is essential to know everything about its prospects and reasons for its popularity. What are the primary reasons that affect it? Experts say that pharma franchise business is different, and hence, it is all the more important to understand it in detail.

75
article thumbnail

Faces of Fuld: Q&A with Kimberlee Luce, Senior Director, Consumer Products + Retail

Fuld

Kimberlee Luce has more than 20 years of experience in business research and consulting and has a unique blend of expertise rooted in opportunity analysis, competitor strategy and building effective distribution models in highly fragmented markets. She has provided market and competitive intelligence to some of the world’s largest and most ambitious companies taking her to places as diverse as Peru, Nigeria and China.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Not Your Typical MSL

The Nontraditional Pharmacist

Dr. Qureshi expands our understanding of the typical Medical Science Liaison role by taking a look at his position in managed markets. Great feature for those considering industry as a career option! Name: Nabeel Qureshi. Title: Medical Liaison, Managed Markets. Interview Summary. Matt [00:00:00] Matt Paterini here with The Nontraditional Pharmacist, part of the Pharmacy Podcast Network.

article thumbnail

Innovative contracting in Europe – a Trojan horse?

pharmaphorum

Overview With pricing of drugs at the centre of political and social debate, the market access and pricing environment in Europe has become increasingly challenging over the years. Innovative contracting has since become a common route to overcome these challenges and ensure timely access for patients. Focus Join us on Monday 2nd September from 15:00-16:00 BST as we discuss the future of innovative contracting with our panel of European payers.

52
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pharmacogenomics Video (Free Sample) – New Addition to Study Materials

Med Ed 101

We are adding a few new videos to our current content and am also updating numerous videos. Atrial fibrillation, asthma, COPD, Vaccines, Ulcerative Colitis, and Crohn’s are few of the many updates I’m working on for the 2020 release! The updates will be done within the next month! I wanted to give you all a […]. The post Pharmacogenomics Video (Free Sample) – New Addition to Study Materials appeared first on Med Ed 101.

article thumbnail

Fuld + Company Provides Global Consumer Products Company Precise Market Sizing & Opportunity Assessment to Inform a Strategic Investment

Fuld

Background + Challenge. An international consumer goods company engaged Fuld + Company to determine the market size and assess marketplace dynamics in a large European country in support of a potential investment by leveraging unique methodology including on the ground field research. The client was unable to use syndicated research for their product in this particular country because the product is sold through traditional trade outlets like corner stores and small shops as opposed to modern tr

58

More Trending

article thumbnail

Pharmacy Cheating Scandal In California – CPJE

Med Ed 101

While I like to focus my time on clinical pharmacy topics, I deeply care about the profession of pharmacy and wanted you to all be aware of this troubling situation. My friend Tony Guerra pays close attention to the numbers surrounding graduation and the pharmacy job market. Needless to say, he has been posting a […]. The post Pharmacy Cheating Scandal In California – CPJE appeared first on Med Ed 101.

40
article thumbnail

Top 5 Lithium Drug Interactions

Med Ed 101

Lithium has numerous clinical pearls that are essential to remember. Of all the educational points about this medication, you must remember some of these important lithium drug interactions. The list below is not an all-inclusive list, just ones that more commonly occur in clinical practice. NSAIDs NSAIDs are well known to impact the serum concentration […].

40
article thumbnail

Top 5 Beers Criteria Updates 2019

Med Ed 101

The Beers Criteria was updated in 2019. Of the numerous updates, I wanted to pull out my top 5 clinically relevant Beers Criteria updates. It is important to note that there were many more updates, but I wanted to share some of the most clinically important updates. Discussed in the video are Beers Criteria updates […]. The post Top 5 Beers Criteria Updates 2019 appeared first on Med Ed 101.

40
article thumbnail

Launch excellence in a disrupted world – challenges & opportunities

pharmaphorum

Overview The launch environment has undergone huge changes as the pharmaceutical industry’s focus has moved from primary care to specialty launch, but its future will be transformed even more radically. The advent of highly novel cell and gene therapies as well as prescription digital therapeutics is providing a serious set of forces for change in the market.

40
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Hydrochlorothiazide, an Unexpected Drug of Abuse

Med Ed 101

I’m a little bummed about my Minnesota Twins. Drug problems are everywhere and my team is not exempt. Apparently, hydrochlorothiazide is a drug of abuse in MLB’s drug testing policy. Mike Pineda, one of the Twins pitchers failed a drug test and was found to have hydrochlorothiazide in his system. In clinical practice, for medical […].

40
article thumbnail

Methotrexate and Thrombocytopenia Case

Med Ed 101

The following case on methotrexate and thrombocytopenia was donated by Kirk Seale, M.S., PharmD, BCGP. Kirk received his Master’s degree in Drug regulatory affairs from the University of Florida and received his PharmD from the University of Mississippi. He has also been appointed to serve on the Government Affairs Committee with The American Society of Consultant […].

40
article thumbnail

Can You Use a TCA With an SNRI? Case Review

Med Ed 101

A 66-year-old female has a past medical history of diabetes, neuropathy, depression, and hypertension. In this case scenario, I discuss the use of a TCA with an SNRI. Her current medication list includes: Aspirin 81 mg daily Capsaicin cream prn Amitriptyline 10 mg at night Metformin 500 mg BID Losartan 50 mg daily Glipizide 5 […]. The post Can You Use a TCA With an SNRI?

40
article thumbnail

Comparing Lorazepam and Diazepam

Med Ed 101

Benzodiazepines are on the Beers criteria. They can have significant adverse effects like sedation, confusion, the risk for dependence, and increased fall risk. We like to avoid benzodiazepines if we can, but what if we do feel that it is necessary (i.e. hospice or other situation)? I have been asked this question before and will […]. The post Comparing Lorazepam and Diazepam appeared first on Med Ed 101.

40
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.